Caxton Associates (New York)’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,237
| Closed | -$679K | – | 484 |
|
|
2023
Q1 | $679K | Sell |
9,237
-5,063
| -35% | -$372K | 0.1% | 206 |
|
|
2022
Q4 | $1.19M | Buy |
14,300
+1,914
| +15% | +$160K | 0.08% | 77 |
|
|
2022
Q3 | $1.2M | Buy |
12,386
+2,424
| +24% | +$235K | 0.16% | 68 |
|
|
2022
Q2 | $1.05M | Buy |
+9,962
| New | +$1.05M | 0.1% | 104 |
|
|
2022
Q1 | – | Sell |
-4,557
| Closed | -$738K | – | 474 |
|
|
2021
Q4 | $738K | Sell |
4,557
-4,249
| -48% | -$688K | 0.08% | 158 |
|
|
2021
Q3 | $1.31M | Buy |
8,806
+7,743
| +728% | +$1.15M | 0.15% | 55 |
|
|
2021
Q2 | $260K | Buy |
+1,063
| New | +$260K | 0.03% | 328 |
|
|
2020
Q4 | – | Sell |
-6,551
| Closed | -$1.55M | – | 123 |
|
|
2020
Q3 | $1.55M | Buy |
6,551
+4,050
| +162% | +$958K | 0.16% | 31 |
|
|
2020
Q2 | $497K | Buy |
2,501
+313
| +14% | +$62.2K | 0.04% | 126 |
|
|
2020
Q1 | $402K | Buy |
+2,188
| New | +$402K | 0.07% | 193 |
|
|
2019
Q2 | – | Sell |
-3,143
| Closed | -$387K | – | 379 |
|
|
2019
Q1 | $387K | Sell |
3,143
-731
| -19% | -$90K | 0.06% | 180 |
|
|
2018
Q4 | $454K | Buy |
3,874
+1,945
| +101% | +$228K | 0.07% | 117 |
|
|
2018
Q3 | $241K | Buy |
+1,929
| New | +$241K | 0.02% | 309 |
|